During pregnancy, 17 beta-estradiol (E2) and progesterone (P) plasma concen
trations increase up to 100-fold. The fetus is exposed to these increasing
amounts of E2 and P. Within 1 d after delivery, E2 and P concentrations fal
l to nonpregnancy concentrations in the mother and the infant. Extremely pr
emature infants are cut off from the placental supply of E2 and P at a very
early developmental stage, and therefore they suffer from this deprivation
for a longer period than infants born at term. Nothing is known about the
consequences of this deprivation, The purpose of this study was to investig
ate how intrauterine concentrations of E2 and P could be maintained after b
irth. In 13 infants with a median gestational age of 26.4 wk (24.1-28.7), a
phospholipid-stabilized soybean oil emulsion available for parenteral nutr
ition that contains different amounts of E2 and P was continuously administ
ered, starting within the first postnatal hours. The supplementation was co
ntinued as long as venous access was indicated but not longer than 6 wk (me
dian 20 d, 12-44). To maintain intrauterine plasma concentrations of 2000-6
000 pg/mL E2 and 300-600 ng/mL P, 2.30 mg.kg(-1).d(-1) E2 (1.13-3.42 mg.kg(
-1).d(-1)) and 21.20 mg.kg(-1).d(-1) P (11.23-27.36 mg.kg(-1).d(-1)) were n
eeded, We conclude that supplementation of E2 and P to maintain intrauterin
e concentrations in extremely premature infants is possible intravenously.
The infants in this study are enrolled in a randomized, controlled pilot st
udy to evaluate the potential benefits of E2 and P supplementation.